Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Cervical Cancer Diagnostic Market 2016 :Industry Insights, Volume Growth, Performance to 2021

Thursday, October 13, 2016 5:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest industry research report on Global Cervical Cancer Diagnostic Market 2016:Industry Size, Shares, Insights, Demand and Analysis to 2022.

Cervical cancer refers to a malignancy of cervical cells. Vaginal bleeding is the most common symptom of this kind of cancer; however, in certain cases, no symptoms are seen until the cancer reaches an advanced stage. More than 90% of cervical malignancies occur due to HPV infection (Human papillomavirus) and they are diagnosed through smear screening. The most common types of cervical cell cancer include Squamous Cell Malignancy and Adenocarcinoma.

A pin-point analysis of the global Cervical Cancer Diagnostic market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. The competitive landscape section focuses on key leaders within the global cervical cancer diagnostic market and their major growth strategies. A deep-dive assessment of segments identifies potential segments which would act as a guide for strategists.

Request a Brochure of This Report, here:

A number of factors contribute to the increasing prevalence of cervical cancer, worldwide. These include rising number of female smokers, large number of patients suffering from HPV infection, growing obese population and increasing incidences of unsafe sex, particularly amongst teenagers. Cancer awareness programs also contribute to the growth of this market. HPV vaccination, inaccurate pap smear testing, ineffective healthcare infrastructure, stringent government regulations and alternative diagnosis methods are some factors, which inhibit the growth of global cervical cancer diagnostic market.

Technological advances in diagnosis, aging population in developed countries and healthcare developments in emerging economies are factors which key leaders in this market could use to their advantage.

Global Cervical Cancer Diagnostic Market by Types

The global cervical cancer diagnostic market is segmented into three categories according to types of diagnostic tests. These categories are Pap Smear Tests, ECC Procedures and Colposcopy Tests. Pap Smear Test is the most effective tool for the diagnosis of HPV It is the sub-segment, which generates the most revenue. This is mainly due to the prevalence of HPV infection in women and the deficiency of the HPV vaccine, which does not cover all types of HPV infections.

Do Inquiry Before Purchasing Report:

Global Cervical Cancer Diagnostic Market by Age Group

The global cervical cancer diagnostic market is segmented into two categories based on age groups: the first category is the age group among 20-40 years and the second is the age group above 40. Cervical cancer has a varying degree of occurrence in different age groups. It can be detected at a young age due to advances in technology. Statistically adult women are most affected by the HPV infection.

Global Cervical Cancer Diagnostic Market by Geography

Geographically, the global cervical cancer diagnostic market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global cervical cancer diagnostic market because of a rising incidence of HPV infection, rising number of women smokers, and growing aged population. Asia-Pacific is the growing market for global cervical cancer diagnostics due to government initiative and improvement in healthcare infrastructure.

Competitive Landscape

The key players within the global cervical cancer diagnostic market include Abott Laboratories, Guided Therapeutics, Olympus, Roche, Ascon Medical Instruments, Cooper Surgical Inc, Cardinal Health, Beckman Coulter Inc. and Siemens Healthcare. There is intense competition for cervical cancer diagnostics due to the large number of cervical cancer patients. Companies are currently focusing on developing advanced techniques of diagnosis such as liquid based cytology.

High Level Analysis

 A comprehensive analysis of the global cervical cancer diagnostic market provides an overview of the market and its key concerns. The market dynamics section covers market drivers, restraints and opportunities within the global cervical cancer diagnostic market and helps in simplifying market behavior. The market is segmented in order to provide information about niche market areas and assist in identifying potential segments. Porter’s Five Forces analysis enables the determination of profitable markets. The suppliers’ bargaining power in the global cervical cancer diagnostic market is moderate due to the existence of numerous suppliers and a large number of consumers. Also, the threat of new entrants is minimal due to strict regulatory requirements. Industrial rivalry is intense because of numerous suppliers competing for cost effective technological advances.


  • This report offers the following benefits:
  • In-depth coverage of the global cervical cancer diagnostic market including drivers, restraints and opportunities would help professionals better understand market behavior
  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global cervical cancer diagnostic market
  • Porter’s Five Forces analysis examines the competitive structure of the global cervical cancer diagnostic market and would assist market strategists
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the global cervical cancer diagnostic market would be informative for professionals in corporate sector
  • The market estimates provided in the report would enable market projections to determine the growth of the global cervical cancer diagnostics market


The global cervical cancer diagnostic market is segmented into three major categories: equipment, application and geography.


  • Pap Smear Tests
  • ECC Procedures
  • Colposcopy Tests


  • Age group between 20 to 40
  • Age group above 40


  • North America
  • Europe
  • Asia-Pacific

About Custom Market Insights:

Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive.

What makes us different from our competitors?

Compared to our competitors, our offerings include, but are not limited to market research services on latest industry trends, customized study at reasonable price, and database bigger than our competitors and provide more relevant results to fit your needs.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.